Current Neuro-Oncology

Volume 27 Number 6
28 February 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 6, 28 February

Huang B, Sun J, Yu L, Xiong J.
Risk Factors Involved in the Blood (Leukocyte-Depleted Suspended Red Blood Cells and Plasma) Transfusion During Glioma Operations.
J Blood Med. 2025 Feb 21;16:83-93. doi: 10.2147/JBM.S493305. PMID: 40007580. Observational study. ˍ

Lee S, Kim M.
Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors.
Medicina (Kaunas). 2025 Feb 21;61(3):376. doi: 10.3390/medicina61030376. PMID: 40142187. Observational study. ˍ

Pratapneni A, Klebaner D, Soltys SG, Rahimy E, Gibbs IC, Chang SD, Li G, Hayden Gephart M, Veeravagu A, Szalkowski GA, Gu X, Wang L, Chuang C, Liu L, Jackson S, Lu R, Skerchak JA, Huang KZ, Wong S, Brown E, Pollom EL.
Single-versus multi-fraction spine stereotactic radiosurgery (ALL-STAR) for patients with spinal metastases: a randomized phase III trial protocol.
BMC Cancer. 2025 Feb 21;25(1):323. doi: 10.1186/s12885-025-13655-6. PMID: 39984889. Interventional study protocol. ˍ

van Steenhoven RW, Salih S, de Vries JM, Smets I, Verdijk RM, Gardeniers M, Kerstens J, Brenner J, Crijnen YS, Geurts M, Bromberg JEC, GeurtsvanKessel CH, Sillevis Smitt PAE, Balvers RK, Titulaer MJ.
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort study.
Ann Clin Transl Neurol. 2025 Feb 21. doi: 10.1002/acn3.70000. PMID: 39981762. Observational study. ˍ

Daoust F, Dallaire F, Tavera H, Ember K, Guiot MC, Petrecca K, Leblond F.
Preliminary study demonstrating cancer cells detection at the margins of whole glioblastoma specimens with Raman spectroscopy imaging.
Sci Rep. 2025 Feb 22;15(1):6453. doi: 10.1038/s41598-025-87109-1. PMID: 39987144. Translational study. ˍ

*Szankai Z, Huggenberger E, Metzler C, Musahl C, Gschwind M.
Within five weeks: Rapidly grown glioblastoma discovered on repeat MRI after pathologic EEG.
Clin Neurophysiol Pract. 2025 Feb 22;10:52-55. doi: 10.1016/j.cnp.2025.02.002. PMID: 40092495. Case report. ˍ

Demetz M, Hecker C, Salim HA, Krigers A, Steinbacher J, Machegger L, Kerschbaumer J, Buchta M, Pöppe J, Geiger P, Spinello A, Kraus TFJ, Griessenauer CJ, Thomé C, Freyschlag CF, Schwartz C.
Epilepsy as primary tumor manifestation correlates with patient status, age, and tumor volume but not with survival in elderly glioblastoma patients: a retrospective bicentric analysis.
Neurosurg Rev. 2025 Feb 24;48(1):264. doi: 10.1007/s10143-025-03397-1. PMID: 39994084. Observational study. ˍ

Enrico G, Fusco E, Palmetti M, Mussa F, Sardi I, Chiappini E, Galli L, Venturini E.
Neurosurgical site infections: a retrospective monocentric study of pediatric brain tumor patients.
Childs Nerv Syst. 2025 Feb 24;41(1):120. doi: 10.1007/s00381-025-06765-w. PMID: 39994029. Observational study. ˍ

Li J, Tao J, Lu H, Fan X, Wang Z, Wang Y, Wang X, Yan W, You Y, Cao Y, Zhang J.
Concurrent Tumor-Treating Fields and Chemoradiotherapy: Outcomes in Grade 4 Glioma Patients.
Clin Med Insights Oncol. 2025 Feb 24;19:11795549251315579. doi: 10.1177/11795549251315579. PMID: 40007556. Observational study. ˍ

Maragno E, Ricchizzi S, Winter NR, Hellwig SJ, Stummer W, Hahn T, Holling M.
Predictive modeling with linear machine learning can estimate glioblastoma survival in months based solely on MGMT-methylation status, age and sex.
Acta Neurochir (Wien). 2025 Feb 24;167(1):52. doi: 10.1007/s00701-025-06441-7. PMID: 39992425. Observational study. ˍ

Green AL, Minard CG, Liu X, Safgren SL, Pinkney K, Harris L, Link G, DeSisto J, Voss S, Nelson MD, Reid JM, Fox E, Weigel BJ, Glade Bender J.
Phase 1 trial of selinexor in pediatric recurrent/refractory solid and CNS tumors (ADVL1414): A Children's Oncology Group Phase 1 Consortium Trial.
Clin Cancer Res. 2025 Feb 25. doi: 10.1158/1078-0432.CCR-24-2754. PMID: 39998852. Observational study˰ ˍ

Kosanam AR, Ma J, White AJ, Murayi R, Soni P, Recinos PF, Kshettry VR.
Comparison of adjuvant radiation versus observation and salvage radiation after subtotal resection of a WHO grade I skull base meningioma: a propensity score-adjusted analysis.
J Neurooncol. 2025 Feb 25. doi: 10.1007/s11060-025-04980-8. PMID: 39998721. Observational study˰ ˍ

Liu J, Lin F, Sun Y, Liu X.
A dual-genotype IDH-mutant infiltrating glioma, a real oligoastrocytoma in cerebral hemisphere.
IBRO Neurosci Rep. 2025 Feb 25;18:366-369. doi: 10.1016/j.ibneur.2025.02.013. PMID: 40092656. Case report. ˍ

Pagnot L, Granger I, Guitton J, Favier B, Ceraulo A, Faure-Conter C, Leblond P, Philippe M.
Real-world pharmacokinetics of trametinib in pediatric low-grade glioma.
Cancer Chemother Pharmacol. 2025 Feb 25;95(1):35. doi: 10.1007/s00280-025-04761-0. PMID: 39998657. Observational study˰ ˍ

Stitzlein LM, Baig MU, Chandra J, McGovern S, Paulino A, Ketonen LM, Khatua S, Zaky W.
Phase I Study of Vorinostat and Temsirolimus in Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma.
Pediatr Blood Cancer. 2025 Feb 25:e31619. doi: 10.1002/pbc.31619? PMID: 40000388. Interventional study˰ ˍ

Alkhatatneh H, Chen YH, Imhoff S, Fogel L, Yao K, Dubin D, Zhang M, Chen P, Nemade A, Herman M, Khatatneh A, Barnes T, Speiser M, Janosky M.
Evaluating the diagnostic ability of treatment response assessment maps (TRAMs)/contrast clearance analysis (CCA) in predicting the presence of active brain tumors.
Neuroradiol J. 2025 Feb 26:19714009251324305. doi: 10.1177/19714009251324305. PMID: 40010303. Observational study. ˍ

Kite T, Yadlapalli V, Herbst J, Karlovits S, Wegner RE, Shepard MJ.
Stereotactic radiosurgery for recurrent high-grade gliomas.
J Clin Neurosci. 2025 Feb 26;135:111150. doi: 10.1016/j.jocn.2025.111150? PMID: 40015114. Observational study˰ ˍ

Slevin F, Hudson EM, Boele FW, Powell JR, Noutch S, Borland M, Brown S, Bruce A, Bulbeck H, Burnet NG, Chang YC, Colaco R, Currie S, Egleston D, Fersht N, Klein M, Lilley J, Lowe M, Miles E, Murray RD, O'Hara DJ, Norris M, Parbutt C, Smith A, Smith C, Whitfield GA, Short S, Murray L.
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial.
BMJ Open. 2025 Feb 26;15(2):e097810. doi: 10.1136/bmjopen-2024-097810. PMID: 40010843. Interventional study protocol. ˍ

Long GV, Shklovskaya E, Satgunaseelan L, Mao Y, da Silva IP, Perry KA, Diefenbach RJ, Gide TN, Shivalingam B, Buckland ME, Gonzalez M, Caixeiro N, Vergara IA, Bai X, Rawson RV, Hsiao E, Palendira U, Phan TG, Menzies AM, Carlino MS, Quek C, Grimmond SM, Vissers JHA, Yeo D, Rasko JEJ, Khasraw M, Neyns B, Reardon DA, Ashley DM, Wheeler H, Back M, Scolyer RA, Drummond J, Wilmott JS, Rizos H.
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.
Nat Med. 2025 Feb 27. doi: 10.1038/s41591-025-03512-1. PMID: 40016450. Case report. ˍ

Veviorskiy A, Mkrtchyan GV, Osipov AN, Izumchenko E, Ozerov IV, Aliper A, Zhavoronkov A, Scheibye-Knudsen M.
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas.
Aging (Albany NY). 2025 Feb 27;null. doi: 10.18632/aging.206212. PMID: 40015963. Observational study. ˍ

Cakmak M, Mohammadian S, Keil VCW, Schouten JW, de Witt Hamer PC, van der Vaart T, Balvers RK, Wamelink IJHG, Barkhof F, van den Bent M, Vries M, Smits M.
How useful is contrast-enhanced MRI in the long-term surveillance of glioma? A multicentre retrospective longitudinal cohort study.
Eur Radiol. 2025 Feb 28. doi: 10.1007/s00330-024-11333-y. PMID: 40016316. Observational study. ˍ

Deboeuf L, Riche M, Malaizé H, Marijon P, Mokhtari K, Bielle F, Tran S, Nichelli L, Jacob J, Touat M, Hoang-Xuan K, Houillier C, Laigle-Donadey F, Reinecke D, Ruge MI, Idbaih A, Mathon B.
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumors.
J Neurosurg. 2025 Feb 28:1-10. doi: 10.3171/2024.10.JNS241948. PMID: 40020233. Observational study˰ ˍ

*Fukami S, Nagai K, Onodera S, Saito Y, Akimoto J, Kohno M.
Photodynamic therapy and tumor-treating fields therapy for newly diagnosed glioblastoma.
Front Oncol. 2025 Feb 28;15:1556669. doi: 10.3389/fonc.2025.1556669. PMID: 40094018. Observational study. ˍ

Margulies A, Sahki N, Rech F, Vogin G, Blonski M, Peiffert D, Taillandier L, Lesanne G, Demogeot N.
Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.
Radiat Oncol. 2025 Feb 28;20(1):28. doi: 10.1186/s13014-025-02611-0. PMID: 40022217. Observational study. ˍ

Reddy SC, Mao Y, Gendreau J, Ahmed AK, Mukherjee D.
Clinical predictors of overall survival in very elderly meningioma patients: a surveillance, epidemiology, and end results (SEER) database analysis.
J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-025-04982-6. PMID: 40019710. Observational study˰ ˍ